Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11041-11050 of 11953

Edit search filters
  1. Associations Between Chemotherapy-Induced Nausea In Patients With Genitourinary Cancer And Changes In Gut Microbiome

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Trans-Pacific Multicenter Collaborative Study Of Minimally Invasive Proximal Versus Total Gastrectomy For Proximal Gastric And Gastroesophageal Junction Cancers

    Rochester, MN

  3. A Study To Measure Hemolysis Markers In Subjects With Warm Autoimmune Hemolytic Anemia

    Rochester, MN

  4. Hepatocellular Carcinoma Early Detection Strategy Study

    Rochester, MN

  5. Clinical And Epidemiological Studies In Pediatric Malignancies

    Rochester, MN

  6. Perfusion MRI For Therapy Response Assessment In Brain Cancer

    Scottsdale/Phoenix, AZ

  7. Detection Of Plasma DNA Methylation In Peripheral Blood From Patients With Hepatocellular Carcinoma

    Rochester, MN

  8. The Impact Of A Geriatric Assessment In Elderly Patients With Multiple Myeloma

    Rochester, MN

  9. Validation Of The NEPHROCLEARTM CCL14 Test In The Intensive Care Unit (ICU) For Risk Assessment Of Persistent Severe Acute Kidney Injury

    Rochester, MN

  10. Cardiolipin Profiling for Barth Syndrome Screening and Characterization

    Rochester, MN

.

Mayo Clinic Footer